Literature DB >> 32160132

PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays.

Abraham Behrmann1, Dalian Zhong1, Li Li, Su-Li Cheng1, Megan Mead1, Bindu Ramachandran1, Parastoo Sabaeifard1, Mohammad Goodarzi2, Andrew Lemoff2, Henry M Kronenberg3, Dwight A Towler1.   

Abstract

RATIONALE: The PTH1R (PTH [parathyroid hormone]/PTHrP [PTH-related protein] receptor) is expressed in vascular smooth muscle (VSM) and increased VSM PTH1R signaling mitigates diet-induced arteriosclerosis in LDLR-/- mice.
OBJECTIVE: To study the impact of VSM PTH1R deficiency, we generated mice SM22-Cre:PTH1R(fl/fl);LDLR-/- mice (PTH1R-VKO) and Cre-negative controls. METHODS AND
RESULTS: Immunofluorescence and Western blot confirmed PTH1R expression in arterial VSM that was reduced by Cre-mediated knockout. PTH1R-VKO cohorts exhibited increased aortic collagen accumulation in vivo, and VSM cultures from PTH1R-VKO mice elaborated more collagen (2.5-fold; P=0.01) with elevated Col3a1 and Col1a1 expression. To better understand these profibrotic responses, we performed mass spectrometry on nuclear proteins extracted from Cre-negative controls and PTH1R-VKO VSM. PTH1R deficiency reduced Gata6 but upregulated the MADS (MCM1, Agamous, Deficiens, and Srf DNA-binding domain)-box transcriptional co-regulator, Mkl-1 (megakaryoblastic leukemia [translocation] 1). Co-transfection assays (Col3a1 promoter-luciferase reporter) confirmed PTH1R-mediated inhibition and Mkl-1-mediated activation of Col3a1 transcription. Regulation mapped to a conserved hybrid CT(A/T)6GG MADS-box cognate in the Col3a1 promoter. Mutations of C/G in this motif markedly reduced Col3a1 transcriptional regulation by PTH1R and Mkl-1. Upregulation of Col3a1 and Col1a1 in PTH1R-VKO VSM was inhibited by small interfering RNA targeting Mkl1 and by treatment with the Mkl-1 antagonist CCG1423 or the Rock (Rho-associated coiled-coil containing protein kinase)-2 inhibitor KD025. Chromatin precipitation demonstrated that VSM PTH1R deficiency increased Mkl-1 binding to Col3a1 and Col1a1, but not TNF, promoters. Proteomic studies of plasma extracellular vesicles and VSM from PTH1R-VKO mice identified C1r (complement component 1, r) and C1s (complement component 1, s), complement proteins involved in vascular collagen metabolism, as potential biomarkers. VSM C1r protein and C1r message were increased with PTH1R deficiency, mediated by Mkl-1-dependent transcription and inhibited by CCG1423 or KD025.
CONCLUSIONS: PTH1R signaling restricts collagen production in the VSM lineage, in part, via Mkl-1 regulatory circuits that control collagen gene transcription. Strategies that maintain homeostatic VSM PTH1R signaling, as reflected in extracellular vesicle biomarkers of VSM PTH1R/Mkl-1 action, may help mitigate arteriosclerosis and vascular fibrosis.

Entities:  

Keywords:  arteriosclerosis; cardiovascular diseases; collagen; fibrosis; transcription factors

Mesh:

Substances:

Year:  2020        PMID: 32160132      PMCID: PMC7524585          DOI: 10.1161/CIRCRESAHA.119.316141

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  72 in total

Review 1.  Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.

Authors:  Ziad Massy; Tilman Drueke
Journal:  J Nephrol       Date:  2017-04-12       Impact factor: 3.902

Review 2.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.

Authors:  Jay D Humphrey; Martin A Schwartz; George Tellides; Dianna M Milewicz
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 3.  Multifaceted Mechanisms of Vascular Calcification in Aging.

Authors:  Luciana A Pescatore; Lionel F Gamarra; Marcel Liberman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-30       Impact factor: 8.311

4.  Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.

Authors:  Jack M Heath; Yong Sun; Kaiyu Yuan; Wayne E Bradley; Silvio Litovsky; Louis J Dell'Italia; John C Chatham; Hui Wu; Yabing Chen
Journal:  Circ Res       Date:  2014-02-13       Impact factor: 17.367

5.  Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein.

Authors:  M D Nyby; T Hino; M E Berger; B L Ormsby; M S Golub; A S Brickman
Journal:  Endocrinology       Date:  1995-06       Impact factor: 4.736

6.  Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.

Authors:  Susanne Muehlich; Ruigong Wang; Seung-Min Lee; Thera C Lewis; Chao Dai; Ron Prywes
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

Review 7.  Parathyroid hormone-related peptide (PTHrP) and parathyroid hormone (PTH)/PTHrP receptor.

Authors:  B Lanske; H M Kronenberg
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1998       Impact factor: 1.807

8.  Loss of function of parathyroid hormone receptor 1 induces Notch-dependent aortic defects during zebrafish vascular development.

Authors:  Caroline Gray; David Bratt; Julie Lees; Marc daCosta; Karen Plant; Oliver J Watson; Sara Solaymani-Kohal; Simon Tazzyman; Jovana Serbanovic-Canic; David C Crossman; Bernard D Keavney; Andrea Haase; Kathryn McMahon; Martin Gering; Henry Roehl; Paul C Evans; Timothy J A Chico
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

Review 9.  Vascular smooth muscle cells in atherosclerosis.

Authors:  Gemma L Basatemur; Helle F Jørgensen; Murray C H Clarke; Martin R Bennett; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2019-06-26       Impact factor: 32.419

10.  Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis.

Authors:  Juyong B Kim; Thomas Quertermous; Robert C Wirka; Dhananjay Wagh; David T Paik; Milos Pjanic; Trieu Nguyen; Clint L Miller; Ramen Kundu; Manabu Nagao; John Coller; Tiffany K Koyano; Robyn Fong; Y Joseph Woo; Boxiang Liu; Stephen B Montgomery; Joseph C Wu; Kuixi Zhu; Rui Chang; Melissa Alamprese; Michelle D Tallquist
Journal:  Nat Med       Date:  2019-07-29       Impact factor: 53.440

View more
  4 in total

Review 1.  Skeletal and extraskeletal disorders of biomineralization.

Authors:  Michael T Collins; Gemma Marcucci; Hans-Joachim Anders; Giovanni Beltrami; Jane A Cauley; Peter R Ebeling; Rajiv Kumar; Agnès Linglart; Luca Sangiorgi; Dwight A Towler; Ria Weston; Michael P Whyte; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2022-05-16       Impact factor: 47.564

2.  FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.

Authors:  Donna Przepiorka; Robert Q Le; Alexei Ionan; Ruo-Jing Li; Ying-Hong Wang; Ramadevi Gudi; Soumya Mitra; Jonathon Vallejo; Olanrewaju O Okusanya; Lian Ma; Yuching Yang; Paresma Patel; Djelila Mezaache; Rakhi Shah; Anamitro Banerjee; Sherita McLamore; Adam N Maung; Kirsten B Goldberg; Richard Pazdur; Marc R Theoret; R Angelo De Claro
Journal:  Clin Cancer Res       Date:  2022-06-13       Impact factor: 13.801

Review 3.  Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis.

Authors:  Lei Wei; Jianjian Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

4.  Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.

Authors:  Felicia Cosman; Linda R Peterson; Dwight A Towler; Bruce Mitlak; Yamei Wang; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.